Table of Contents

company-logo

Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN1 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 foe the treatment of for SLC13A5 Deficiency; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments. The company was incorporated in 2019 and is based in Dallas, Texas.

Taysha Gene Therapies Dividend Announcement

• Taysha Gene Therapies does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Taysha Gene Therapies dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Taysha Gene Therapies Dividend History

Taysha Gene Therapies Dividend Yield

Taysha Gene Therapies current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Taysha Gene Therapies stock? Use our calculator to estimate your expected dividend yield:

Taysha Gene Therapies Financial Ratios

P/E ratio-33.99
PEG ratio0.28
P/B ratio8.72
ROE-27.90%
Payout ratio0.00%
Current ratio5.51
Quick ratio5.51
Cash Ratio5.38

Taysha Gene Therapies Dividend FAQ

Does Taysha Gene Therapies stock pay dividends?
Taysha Gene Therapies does not currently pay dividends to its shareholders.
Has Taysha Gene Therapies ever paid a dividend?
No, Taysha Gene Therapies has no a history of paying dividends to its shareholders. Taysha Gene Therapies is not known for its dividend payments.
Why doesn't Taysha Gene Therapies pay dividends?
There are several potential reasons why Taysha Gene Therapies would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Taysha Gene Therapies ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Taysha Gene Therapies has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Taysha Gene Therapies a dividend aristocrat?
Taysha Gene Therapies is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Taysha Gene Therapies a dividend king?
Taysha Gene Therapies is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Taysha Gene Therapies a dividend stock?
No, Taysha Gene Therapies is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Taysha Gene Therapies stocks?
To buy Taysha Gene Therapies you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Taysha Gene Therapies stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.